Abstract
In the last 10 years, the importance of smoking cessation among cancer patients and survivors has become increasingly recognized as an essential element of high-quality cancer care. A number of leading oncology organizations and accrediting bodies have recommended integration of smoking cessation services into routine cancer care. However, barriers to smoking cessation in cancer survivors are many, and implementation of smoking cessation services in cancer care has been slow and inconsistent. In this chapter, we will (1) describe the current evidence supporting the importance of providing smoking cessation services to cancer survivors and their families; (2) review prevalence rates of smoking and cessation in this population; (3) review clinical practice guidelines for the delivery of evidence-based, smoking cessation interventions in cancer care; (4) summarize the multilevel challenges of promoting smoking cessation among cancer survivors receiving follow-up care across all healthcare settings; and (5) highlight future research directions for promoting smoking cessation in cancer survivorship across the trajectory of care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
These patient education materials are available from the authors by request.
References
National Cancer Institute. Cancer Survivors and Smoking. 2017. Available from: https://progressreport.cancer.gov/after/smoking.
U.S. Department of Health and Human Services. The health consequences of smoking - 50 years of progress: A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014.
National Cancer Institute. Cancer Statistics: National Cancer Institute. 2017. Available from: https://www.cancer.gov/about-cancer/understanding/statistics.
Tobacco and Cancer: An American Association for Cancer Research Policy Statement [Internet]. 2010. Available from: http://www.aacr.org/AdvocacyPolicy/GovernmentAffairs/Documents/TobaccoandCancerStatement___E086A2.pdf.
Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, et al. Smoking cessation, version 1.2016, NCCN clinical practice guidelines in oncology. J National Compreh Cancer Network: JNCCN. 2016;14(11):1430–68. Available from: https://www.iaslc.org/sites/default/files/wysiwyg-assets/nccn_smoking_0916.pdf.
National Comprehensive Cancer Network. NCCN Publishes New Guidelines for Smoking Cessation. 2015. Available from: https://www.nccn.org/about/news/newsinfo.aspx?NewsID=498.
Goldstein MG, Niaura R, Willey C, Kazura A, Rakowski W, DePue J, et al. An academic detailing intervention to disseminate physician-delivered smoking cessation counseling: smoking cessation outcomes of the physicians counseling smokers project. Prev Med. 2003;36(2):185–96.
Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res. 2002;105(1):53–7.
Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9(5):258–62.
Warren GW, Marshall JR, Cummings MK, Toll BA, Gritz ER, Hutson A, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thor Onc. 2013;8(5):543–8.
Goldstein AO, Ripley-Moffitt CE, Pathman DE, Patsakham KM. Tobacco use treatment at the U.S. National Cancer Institute's designated cancer centers. Nicotine Tob Res. 2013;15(1):52–8.
McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156–70.
Taylor KL, Cox LS, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007;56(1):125–34.
McBride CM, Blocklin M, Lipkus IM, Klein WM, Brandon TH. Patient's lung cancer diagnosis as a cue for relatives' smoking cessation: evaluating the constructs of the teachable moment. Psychooncology. 2017;26(1):88–95.
Weaver KE, Rowland JH, Augustson E, Atienza AA. Smoking concordance in lung and colorectal cancer patient-caregiver dyads and quality of life. Cancer Epidemiol Biomark Prev. 2011;20(2):239–48.
Ebbert JO, Rowland LC, Montori V, Vickers KS, Erwin PC, Dale LC, et al. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2004;3:CD004306.
Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. CD004306Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:Cd010216.
Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014;120(22):3527–35.
Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Oncol. 2015;33(8):952–63.
Warren GW, Sobus S, Gritz ER. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. 2014;15(12):e568–80.
Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, et al. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012;136(2):521–33.
Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol. 2014;65(4):742–54.
Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007;30(5):531–9.
Garces YI, Yang P, Parkinson J, Zhao X, Wampfler JA, Ebbert JO, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004;126(6):1733–41.
Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA. 2011;305(24):2548–55.
Murin S, Inciardi J. Cigarette smoking and the risk of pulmonary metastasis from breast cancer. Chest. 2001;119(6):1635–40.
Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. Br Med J. 2010;340:b5569.
Peppone LJ, Mustian KM, Morrow GR, Dozier AM, Ossip DJ, Janelsins MC, et al. The effect of cigarette smoking on cancer treatment-related side effects. Oncologist. 2011;16(12):1784–92.
Sharp L, McDevitt J, Carsin AE, Brown C, Comber H. Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study. Cancer Epidemol Biomarkers Prev. 2014;23(11):2579–90.
Waggoner SE, Darcy KM, Fuhrman B, Parham G, Lucci J 3rd, Monk BJ, et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a gynecologic oncology group study. Gynecol Oncol. 2006;103(3):853–8.
Walter V, Jansen L, Hoffmeister M, Brenner H. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol. 2014;25(8):1517–25.
Warren GW, Kasza KA, Reid ME, Cummings MK, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401–10.
Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, Luu Q, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int Radiat Oncol Biol Phys. 2011;79(2):414–9.
Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst. 2002;94(3):182–92.
Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26(3):392–8.
van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A. Van den belt-Dusebout AW, Noyon R, et al. roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. Natl. Cancer Inst. 1995;87(20):1530–7.
Nielsen SF, Nordestgaard BG, Bojesen SE. Associations between first and second primary cancers: a population-based study. CMAJ. 2012;184(1):E57–69.
Tabuchi T, Ito Y, Ioka A, Nakayama T, Miyashiro I, Tsukuma H. Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study. Ann Oncol. 2013;24(10):2699–704.
USDHHS. The health benefits of smoking cessation. Washington, D.C: A Report of the surgeon general. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 1990.
Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer. 2006;106(11):2428–36.
Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20(17):3651–7.
Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917–21.
Duffy SA, Terrell JE, Valenstein M, Ronis DL, Copeland LA, Connors M. Effect of smoking, alcohol, and depression on the quality of life of head and neck cancer patients. Gen Hosp Psychiatry. 2002;24(3):140–7.
Shen MJ, Hamann HA, Thomas AJ, Ostroff JS. Association between patient-provider communication and lung cancer stigma. Support Care Cancer. 2016;24(5):2093–9.
Hamann HA, Ostroff JS, Marks EG, Gerber DE, Schiller JH, Lee SJ. Stigma among patients with lung cancer: a patient-reported measurement model. Psychooncology. 2014;23(1):81–92.
Park CL, Gaffey AE. Relationships between psychosocial factors and health behavior change in cancer survivors: an integrative review. Ann Behav Med. 2007;34(2):115–34.
Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. Clin Oncol. 2005;23(34):8884–93.
Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults in the United States. 2015. Available from: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm.
Westmaas JL, Alcaraz KI, Berg CJ, Stein KD. Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomark Prev. 2014;23(9):1783–92.
Coups EJ, Ostroff JS. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med. 2005;40(6):702–11.
Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, et al. Health behaviors in cancer survivors. Oncol Nurs Forum. 2007;34(3):643–51.
Emmons K, Li FP, Whitton J, Mertens AC, Hutchinson R, Diller L, et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. J Clin Oncol. 2002;20(6):1608–16.
Knudsen N, Schulman S, van den Hoek J, Fowler R. Insights on how to quit smoking: a survey of patients with lung cancer. Cancer Nurs. 1985;8(3):145–50.
Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L, et al. Cigarette smoking patterns in patients after treatment of bladder cancer. Cancer Educ. 2000;15(2):86–90.
Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569–76.
Sanderson Cox L, Patten CA, Ebbert JO, Drews AA, Croghan GA, Clark MM, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. Clin Oncol. 2002;20(16):3461–9.
Silverman S Jr, Gorsky M, Greenspan D. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dent Assoc. 1983;106(1):33–5.
Stevens MH, Gardner JW, Parkin JL, Johnson LP. Head and neck cancer survival and life-style change. Arch Otolaryngol. 1983;109(11):746–9.
Vander Ark W, DiNardo LJ, Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope. 1997;107(7):888–92.
National Comprehensive Cancer Network. Practice guidelines in oncology. 2006. Available from: http://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf.
Whitlock EP, Orleans CT, Pender N, Allan J. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am Prev Med. 2002;22(4):267–84.
Vidrine JI, Shete S, Cao Y, Greisinger A, Harmonson P, Sharp B, et al. Ask-advise-connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med. 2013;173(6):458–64.
Fiore MC, Jaen, RC, Baker,TB, Bailey,WC, Benowitz, NL, Curry SJ, Dorfman, SF , Froelicher ES, Goldstein MG, et al. Treating tobacco use and dependence (clinical practice guideline)-2008 Update : U.S. Department of Health and Human Services, Public Health Service; 2008.Avaiable from: https://bphc.hrsa.gov/buckets/treatingtobacco.pdf.
Stead LF, Lancaster T. Smoking prevalence and management among cancer survivors. Cochrane Database Syst Rev. 2012;10:Cd008286.
Ehrenzeller MF, Mayer DK, Goldstein A. Smoking prevalence and management among cancer survivors. Oncol Nurs Forum. 2018;45(1):55–68.
Oncology Nursing Society. ISNCC Tobacco Position Statement. 2014. Available from: https://www.ons.org/advocacy-policy/positions/policy/tobacco.
Hanna N, Mulshine J, Wollins DS, Tyne C, Dresler C. Tobacco cessation and control a decade later: American society of clinical oncology policy statement update. Clin Oncol. 2013;31(25):3147–57.
Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013;19(8):1941–8.
Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemol Biomarkers Prev. 2005;14(10):2287–93.
Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, et al. Research priorities, measures, and recommendations for assessment of tobacco use in clinical cancer research. Clinical Cancer Res. 2016;22(8):1907–13.
Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149(2):200–11.
Wewers ME, Bowen JM, Stanislaw AE, Desimone VBA. Nurse-delivered smoking cessation intervention among hospitalized postoperative patients--influence of a smoking-related diagnosis: a pilot study. Heart Lung. 1994;23(2):151–6.
Wewers ME, Jenkins L, Mignery TA. Nurse-managed smoking cessation intervention during diagnostic testing for lung cancer. Oncol Nurs Forum. 1997;24(8):1419–22.
Sitas F, Weber MF, Egger S, Yap S, Chiew M, O'Connell D. Smoking cessation after cancer. J Clin Oncol. 2014;32(32):3593–5.
Park ER, Ostroff JS, Perez GK, Hyland KA, Rigotti NA, Borderud S, et al. Integrating tobacco treatment into cancer care: study protocol for a randomized controlled comparative effectiveness trial. Cont Clin Trials. 2016;50:54–65.
Morgan G, Schnoll RA, Alfano CM, Evans SE, Goldstein A, Ostroff J, et al. National Cancer Institute conference on treating tobacco dependence at cancer centers. J Oncol Pract. 2011;7(3):178–82.
Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomark Prev. 2014;23(1):3–9.
Schnoll RA, James C, Malstrom M, Rothman RL, Wang H, Babb J, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med. 2003;25(3):214–22.
Schnoll RA, Malstrom M, James C, Rothman RL, Miller SM, Ridge JA, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002;46(2):137–45.
Schnoll RA, Rothman RL, Newman H, Lerman C, Miller SM, Movsas B, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology. 2004;13(5):346–58.
Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med. 2005;30(1):1–11.
Burris JL, Studts JL, DeRosa AP, Ostroff JS. Systematic review of tobacco use after lung or head/neck cancer diagnosis: results and recommendations for future research. Cancer Epidemiol Biomark Prev. 2015;24(10):1450–61.
Jonnalagadda S, Bergamo C, Lin JJ, Lurslurchachai L, Diefenbach M, Smith C, et al. Beliefs and attitudes about lung cancer screening among smokers. Lung Cancer. 2012;77(3):526–31.
Wold KS, Byers T, Crane LA, Ahnen D. What do cancer survivors believe causes cancer? (United States). Cancer Causes Control. 2005;16(2):115–23.
Siu AL, Preventive Services Task Force US. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(8):622–34.
Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the US preventive services task force. Rockville (MD): Agency for Healthcare Research and Quality (US). 2015.
Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Other supporting document for tobacco smoking cessation in adults, including pregnant women: behavioral and pharmacotherapy interventions 2015. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/behavioral-counseling-and-pharmacotherapy-interventions-for-/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions1.
Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull. 2003;129(2):270–304.
Meijer A, Roseman M, Delisle VC, Milette K, Levis B, Syamchandra A, et al. Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res. 2013;75(1):1–17.
Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28.
Simmons VN, Litvin EB, Jacobsen PB, Patel RD, McCaffrey JC, Oliver JA, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119(7):1420–7.
Rigotti NA, Clair C, Munafò MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;5:CD001837–CD.
Karam-Hage M, Cinciripini PM, Gritz ER. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014;64(4):272–90.
MD Anderson Cancer Center- The University of Texas. Tobacco Cessation Algorithm- Adult 2016 [1–7]. Available from: https://www.mdanderson.org/documents/for-physicians/algorithms/screening/risk-reduction-tobacco-cessation-web-algorithm.pdf.
Kaul S, Avila JC, Jupiter D, Rodriguez AM, Kirchhoff AC, Kuo YF. Modifiable health-related factors (smoking, physical activity and body mass index) and health care use and costs among adult cancer survivors. J Cancer Res Clin Oncol. 2017;143(12):2469–80.
Heitz AE, Baumgartner RN, Baumgartner KB, Boone SD. Healthy lifestyle impact on breast cancer-specific and all-cause mortality. Breast Cancer Res Treat. 2018 Jan;167(1):171–181.
Christakis NA, Fowler JH. The collective dynamics of smoking in a large social network. N Engl J Med. 2008;358(21):2249–58.
Akinboro O, Olorunfemi O, Basak P, Phillips E, Pomerantz D, Bernhardt B, et al. Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States: 1999-2012. Cancer Epidemiol Biomark Prev. 2017;26(8):1296–305.
Kahalley LS, Robinson LA, Tyc VL, Hudson MM, Leisenring W, Stratton K, et al. Risk factors for smoking among adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2012;58(3):428–34.
Thong AE, Petruzella S, Orlow I, Zabor EC, Ehdaie B, Ostroff JS, et al. Accuracy of self-reported smoking exposure among bladder cancer patients undergoing surveillance at a tertiary referral center. Eur Urol Focus. 2016;2(4):441–4.
Alberg AJ, Worley ML, Tooze JA, Hatcher JL, Carpenter MJ, Day TA, et al. The validity of self-reported recent smoking in head and neck cancer surgical patients. Otolaryngol Head Neck Surg. 2015;153(6):990–5.
Morales NA, Romano MA, Michael Cummings K, Marshall JR, Hyland AJ, Hutson A, et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. 2013;24(6):1223–30.
Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006;106(1):17–27.
Gichuki JW, Opiyo R, Mugyenyi P, Healthcare Providers NK. Level of involvement in provision of smoking cessation interventions in public health facilities in Kenya. J Public Health Africa. 2015;6(2):523.
Panda R, Persai D, Venkatesan S, Ahluwalia JS. Physician and patient concordance of report of tobacco cessation intervention in primary care in India. BMC Public Health. 2015;15:456.
Anczak JD, Nogler RA. Tobacco cessation in primary care: maximizing intervention strategies. Clin Med Res. 2003;1(3):201–16.
Sarna LP, Brown JK, Lillington L, Rose M, Wewers ME, Brecht ML. Tobacco interventions by oncology nurses in clinical practice: report from a national survey. Cancer. 2000;89(4):881–9.
Cooley ME, Emmons KM, Haddad R, Wang Q, Posner M, Bueno R, et al. Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer. 2011;117(13):2961–9.
Wells M, Aitchison P, Harris F, Ozakinci G, Radley A, Bauld L, et al. Barriers and facilitators to smoking cessation in a cancer context: a qualitative study of patient, family and professional views. BMC Cancer. 2017;17(1):348.
Fuhrmans V. Case grows to cover quitting. The Wall Street Journal. 2005 Apr;26:D1.
American Lung Association. Billing guide for tobacco screening and cessation. 2018. https://www.lung.org/assets/documents/tobacco/billing-guide-for-tobacco.pdf. Accessed 7 Oct 2018.
Land SR, Warren GW, Crafts JL, Hatsukami DK, Ostroff JS, Willis GB, et al. Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research. Cancer. 2016;122(11):1728–34.
Zapka J, Goins KV, Pbert L, Ockene JK. Translating efficacy research to effectiveness studies in practice: lessons from research to promote smoking cessation in community health centers. Health Promot Pract. 2004;5(3):245–55.
Amato KAD, Zevon M, Hysert P, Hysert R, Segal S, Reed R, et al. Evaluation of a dedicated institutional tobacco cessation service for thoracic clinic cancer patients. Clin Oncol. 2013;31(15 suppl):1603.
Karam-Hage M, Oughli HA, Rabius V, Beneventi D, Wippold RC, Blalock JA, et al. Tobacco cessation treatment pathways for patients with cancer: 10 years in the making. Natl Compr Canc Netw. 2016;14(11):1469–77.
Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2010;21(6):811–20.
Hamann HA, Shen M, Thomas AJ, Lee SJ, Ostroff J. Development and preliminary psychometric evaluation of a patient-reported outcome measure for lung cancer stigma: the lung cancer stigma inventory (LCSI). Stigma and Health. 2017.
Emmons KM, Puleo E, Sprunck-Harrild K, Ford J, Ostroff JS, Hodgson D, et al. Partnership for health-2, a web-based versus print smoking cessation intervention for childhood and young adult cancer survivors: randomized comparative effectiveness study. J Med Internet Res. 2013;15(11):e218.
McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 2003;10(4):325–33.
Acknowledgment
This work was made possible in part by funding from grants awarded by the National Cancer Institute (R01CA090514, T32CA009461).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ostroff, J.S., Riley, K.E., Dhingra, L.K. (2018). Smoking. In: Feuerstein, M., Nekhlyudov, L. (eds) Handbook of Cancer Survivorship. Springer, Cham. https://doi.org/10.1007/978-3-319-77432-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-77432-9_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77430-5
Online ISBN: 978-3-319-77432-9
eBook Packages: MedicineMedicine (R0)